The acquisition will enable Prism, an ophthalmology and retina management company with 180 providers, 91 office locations, and seven ASCs, to enhance its focus on data analytics, clinical research investments, and biopharma partnerships, according to a Feb. 4 news release from McKesson.
Prism Vision physicians will retain a 20% ownership stake in the company. Pending regulatory approval, Prism will be integrated into McKesson’s U.S. Pharmaceutical segment.
At the Becker's 23rd Annual Spine, Orthopedic and Pain Management-Driven ASC + The Future of Spine Conference, taking place June 11-13 in Chicago, spine surgeons, orthopedic leaders and ASC executives will come together to explore minimally invasive techniques, ASC growth strategies and innovations shaping the future of outpatient spine care. Apply for complimentary registration now.
